Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Cantab Biopharmaceuticals Ltd
Cantab Biopharmaceuticals Ltd
Activities:
Manufacturing
Drug Delivery
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription
With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
Challenging agency guidance: what to do when NICE gets it “wrong”
Catherine Penny, Managing Associate at law firm Stevens & Bolton, offers advice regarding how healthcare organisations can challenge NICE guidelines
EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications
16 January 2025 | Virtual
Isopod rapid cleanrooms helping life science start-ups and smaller businesses grow
The Guardtech Group’s quick-assembly pods provide a fast, high-quality cleanroom solution
etherna and Dropshot team up to optimise the RNA drug development process in $950m deal
The two companies will combine their LNP and mRNA-based technologies to develop precision medicines for cardiac and renal diseases
Upcoming event
EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications
16 January 2025 | Virtual
See all
Related Content
Research & Development
Selcia and Cantab announce drug discovery collaboration
To develop improved antibiotics for multi-drug resistant Gram-negative bacterial infections
Research & Development
Celtic Pharma Holdings funds biosuperiors development at Cantab
Celtic Pharma Holdings has made £5m of private equity funding available to Cantab Biopharmaceuticals (CBL) over three years for the development of improved biological medicines.
Subscribe now